Does GOLIMUMAB Cause Basal cell carcinoma? 384 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 384 reports of Basal cell carcinoma have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.6% of all adverse event reports for GOLIMUMAB.
384
Reports of Basal cell carcinoma with GOLIMUMAB
0.6%
of all GOLIMUMAB reports
1
Deaths
246
Hospitalizations
How Dangerous Is Basal cell carcinoma From GOLIMUMAB?
Of the 384 reports, 1 (0.3%) resulted in death, 246 (64.1%) required hospitalization, and 8 (2.1%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 384 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which GOLIMUMAB Alternatives Have Lower Basal cell carcinoma Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN